Value of Trans-lymphatic Contrast-enhanced Ultrasound in the Diagnosis of Cervical Lymph Node Metastasis of Thyroid Cancer
Yan ZHANG; Bing MA; Jia-Hang ZHAO; Ying ZHANG; Jia-Ning ZHU; Ping ZHAO; Yu-Kun LUO.
Acta Academiae Medicinae Sinicae
; (6): 338-342, 2021.
ArtÃculo en Zh | WPRIM | ID: wpr-887864
Documentos relacionados
[Value of Trans-lymphatic Contrast-enhanced Ultrasound in the Diagnosis of Cervical Lymph Node Metastasis of Thyroid Cancer].
The value of contrast-enhanced ultrasound for the diagnosis of metastatic cervical lymph nodes of papillary thyroid carcinoma: A systematic review and meta-analysis.
Utility of sonography for identifying metastatic cervical adenopathy in children with differentiated thyroid carcinoma at presentation.
Predicting central lymph node metastasis in patients with papillary thyroid carcinoma based on ultrasound radiomic and morphological features analysis.
[Research Status and Prospect of New Ultrasound Technology in Predicting Cervical Lymph Node Metastasis of Thyroid Papillary Carcinoma].
Dual-modal radiomics for predicting cervical lymph node metastasis in papillary thyroid carcinoma.
Non-invasive molecular imaging for precision diagnosis of metastatic lymph nodes: opportunities from preclinical to clinical applications.
False-positive supraclavicular lymph node detected on chest computed tomography in oncology patients: Clinical implication based on subsequent neck ultrasonography and ultrasonography-guided tissue sampling.
Contrast-enhanced US with Perfluorobutane to Diagnose Small Lateral Cervical Lymph Node Metastases of Papillary Thyroid Carcinoma.
Ultrasound-based radiomics machine learning models for diagnosing cervical lymph node metastasis in patients with non-small cell lung cancer: a multicentre study.